These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins. van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738 [TBL] [Abstract][Full Text] [Related]
3. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620 [TBL] [Abstract][Full Text] [Related]
4. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis. Truneh A; Reddy M; Ryan P; Lyn SD; Eichman C; Couez D; Hurle MR; Sekaly RP; Olive D; Sweet R Mol Immunol; 1996 Feb; 33(3):321-34. PubMed ID: 8649453 [TBL] [Abstract][Full Text] [Related]
6. What's the difference between CD80 and CD86? Sansom DM; Manzotti CN; Zheng Y Trends Immunol; 2003 Jun; 24(6):314-9. PubMed ID: 12810107 [TBL] [Abstract][Full Text] [Related]
7. CD80 binding polyproline helical peptide inhibits T cell activation. Srinivasan M; Lu D; Eri R; Brand DD; Haque A; Blum JS J Biol Chem; 2005 Mar; 280(11):10149-55. PubMed ID: 15598660 [TBL] [Abstract][Full Text] [Related]
8. Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4. Fargeas CA; Truneh A; Reddy M; Hurle M; Sweet R; Sékaly RP J Exp Med; 1995 Sep; 182(3):667-75. PubMed ID: 7544393 [TBL] [Abstract][Full Text] [Related]
9. Differential down-regulation of CD28 by B7-1 and B7-2 engagement. Eck SC; Chang D; Wells AD; Turka LA Transplantation; 1997 Nov; 64(10):1497-9. PubMed ID: 9392322 [TBL] [Abstract][Full Text] [Related]
10. CD80 cytoplasmic domain controls localization of CD28, CTLA-4, and protein kinase Ctheta in the immunological synapse. Tseng SY; Liu M; Dustin ML J Immunol; 2005 Dec; 175(12):7829-36. PubMed ID: 16339518 [TBL] [Abstract][Full Text] [Related]
11. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409 [TBL] [Abstract][Full Text] [Related]
12. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain. Guo Y; Wu Y; Zhao M; Kong XP; Liu Y J Exp Med; 1995 Apr; 181(4):1345-55. PubMed ID: 7535334 [TBL] [Abstract][Full Text] [Related]
13. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482 [TBL] [Abstract][Full Text] [Related]
14. CD80 costimulation is essential for the induction of airway eosinophilia. Harris N; Peach R; Naemura J; Linsley PS; Le Gros G; Ronchese F J Exp Med; 1997 Jan; 185(1):177-82. PubMed ID: 8996254 [TBL] [Abstract][Full Text] [Related]
15. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis. Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960 [TBL] [Abstract][Full Text] [Related]
16. A theoretical framework for quantitative analysis of the molecular basis of costimulation. Jansson A; Barnes E; Klenerman P; Harlén M; Sørensen P; Davis SJ; Nilsson P J Immunol; 2005 Aug; 175(3):1575-85. PubMed ID: 16034096 [TBL] [Abstract][Full Text] [Related]
17. Molecular and Functional Analyses of the Primordial Costimulatory Molecule CD80/86 and Its Receptors CD28 and CD152 (CTLA-4) in a Teleost Fish. Lu TZ; Liu X; Wu CS; Ma ZY; Wang Y; Zhang YA; Zhang XJ Front Immunol; 2022; 13():885005. PubMed ID: 35784316 [TBL] [Abstract][Full Text] [Related]
18. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. Krummel MF; Allison JP J Exp Med; 1995 Aug; 182(2):459-65. PubMed ID: 7543139 [TBL] [Abstract][Full Text] [Related]
19. Differential requirement for CD28/CTLA-4-CD80/CD86 interactions in drug-induced type 1 and type 2 immune responses to trinitrophenyl-ovalbumin. Nierkens S; Aalbers M; Bol M; Bleumink R; van Kooten P; Boon L; Pieters R J Immunol; 2005 Sep; 175(6):3707-14. PubMed ID: 16148116 [TBL] [Abstract][Full Text] [Related]
20. The CD28-B7 costimulatory pathway and its role in autoimmune disease. Daikh D; Wofsy D; Imboden JB J Leukoc Biol; 1997 Aug; 62(2):156-62. PubMed ID: 9261329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]